A detailed history of Carrera Capital Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Carrera Capital Advisors holds 25,546 shares of GILD stock, worth $2.47 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
25,546
Previous 20,660 23.65%
Holding current value
$2.47 Million
Previous $1.42 Billion 51.09%
% of portfolio
0.52%
Previous 0.46%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$66.59 - $83.99 $325,358 - $410,375
4,886 Added 23.65%
25,546 $2.14 Billion
Q2 2024

Aug 27, 2024

BUY
$63.15 - $72.88 $1.3 Million - $1.51 Million
20,660 New
20,660 $1.42 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $121B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Carrera Capital Advisors Portfolio

Follow Carrera Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carrera Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Carrera Capital Advisors with notifications on news.